Who is sponsoring NCT02772120?

NCT02772120 is sponsored by Brigham and Women's Hospital.

What condition does NCT02772120 study?

NCT02772120 studies Infertility.

What drugs are being tested in NCT02772120?

Interventions: Vaginal progesterone gel (Crinone® 8%), Intramuscular Progesterone.

What is the status of NCT02772120?

NCT02772120 is currently WITHDRAWN.

Last reviewed 2019-09-06 · How we verify

Comparison of Vaginal Progesterone Gel (Crinone 8%®) and Intramuscular Progesterone in Vitrified-Warmed Blastocyst Transfer Cycles

NCT02772120 Phase 4 WITHDRAWN

The aim of this study is to test the hypothesis that the pregnancy rates of women (ages 18-50 years) undergoing transfer of vitrified-warmed blastocysts (frozen at less than 41 years of age) as part of their IVF treatment are not different with respect to the administration of progesterone (Crinone® 8% vaginal gel versus intramuscular progesterone).

Details

Lead sponsor	Brigham and Women's Hospital
Phase	Phase 4
Status	WITHDRAWN

Conditions

Infertility

Interventions

Vaginal progesterone gel (Crinone® 8%)
Intramuscular Progesterone

Primary outcomes

Clinical pregnancy rate — 5-6 weeks
Percentage of patients with intrauterine gestational sac by ultrasound

Countries

United States